Richter's Syndrome
Richter's Syndrome is a condition where chronic lymphocytic leukemia (CLL) transforms into a more aggressive type of lymphoma, leading to symptoms such as swollen lymph nodes, fever, and weight loss.
Richter's Syndrome: M-CHOP with Mosunetuzumab
We are studying a new treatment combining mosunetuzumab with CHOP for patients with Richter's Syndrome who have not had therapy before. The aim is to evaluate its effectiveness and safety.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 79 years old?
- Are you pregnant or breastfeeding, or planning to become pregnant in the next 3 months?
- Do you have any autoimmune disorders, such as lupus or rheumatoid arthritis?
- Have you had any major surgery in the last 4 weeks?
- Are you currently taking any medications that could affect your immune system, like steroids?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Adriacept Blasen-Instillations-Set
Adriamycin
Adriblastin
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitari Vall D Hebron
Hematology
Barcelona, Spain
Hospital Universitario De La Princesa
Hematology
Ciudad Lineal, Spain
Hospital Universitario Donostia
Hematology
Donostia / San Sebastián, Spain
Sponsor: Grupo Espanol De Leucemia Linfocitica Cronica
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.